Pharmacy Rules Soon To Regulate Online Portals: Government
Government may soon finalise e-pharmacy rules which would regulate online platforms selling medicines and issuing medication. According to sources, a regulatory framework is likely to be worked out to ensure proper monitoring and registration of such platforms, due to rising concerns over possible misuse of such avenues for distribution of illegal or outdated medicines.
Sources further said that the draft e-pharmacy rules would be aimed at removing all the uncertainties prevailing in the fast paced digital markets in the absence of any regulation till date.
The Department for Promotion of Industry and Internal Trade (DPIIT) and the pharmacy industry are likely to work out the e-pharmacy rules which would be in form of a regulatory framework, sources said further.
During consultations between the department and the industry, concerns over possible misuse of such avenues for distribution of illegal or unethical medicines or outdated, substituted, or counterfeit medications amid absence of regulations have been raised.
Stringent regulation of the e-health and e-pharmacy sector is essential in view of the potential harm it can cause to health of end user in case misuse, a source aware of the development said.
Therefore work may soon start on drafting e-pharmacy rules to regulate and also register online platforms selling medicines and issuing medication.
The rules may include aspects like due diligence measures to be undertaken by the e-pharmacy or e-health platforms, mandatory registration with the appropriate authority for sale of drugs, assigning responsibility on such platforms for the sale of genuine drugs and  regulating the sale of controlled drugs.
-
We May Need Another Tukaram Mundhe To Fight Air Pollution | The Reason Why
Developers may install basic measures such as sprinklers and green nets, resume work, and continue violating rules when this equipment stops working.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.